[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,782,689
  • Shares Outstanding, K 535,342
  • Annual Sales, $ 74,680 K
  • Annual Income, $ -644,760 K
  • EBIT $ -544 M
  • EBITDA $ -460 M
  • 60-Month Beta 1.07
  • Price/Sales 24.37
  • Price/Cash Flow N/A
  • Price/Book 1.95

Options Overview Details

View History
  • Implied Volatility 89.44% (-9.27%)
  • Historical Volatility 64.10%
  • IV Percentile 46%
  • IV Rank 17.15%
  • IV High 222.65% on 01/14/26
  • IV Low 61.86% on 08/11/26
  • Expected Move (DTE 2) 0.24 (6.94%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 1,221
  • Volume Avg (30-Day) 16,032
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 393,981
  • Open Int (30-Day) 359,094
  • Expected Range 3.19 to 3.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.23
  • Number of Estimates 4
  • High Estimate $-0.20
  • Low Estimate $-0.24
  • Prior Year $-0.36
  • Growth Rate Est. (year over year) +36.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.92 +17.29%
on 08/18/26
3.63 -5.64%
on 08/21/26
+0.42 (+14.17%)
since 07/31/26
3-Month
2.84 +20.60%
on 07/20/26
4.09 -16.26%
on 07/06/26
-0.18 (-5.12%)
since 06/02/26
52-Week
2.77 +23.65%
on 05/19/26
7.18 -52.30%
on 10/20/25
-1.23 (-26.50%)
since 09/02/25

Most Recent Stories

More News
Recursion Pharmaceuticals: Q2 Earnings Snapshot

Recursion Pharmaceuticals: Q2 Earnings Snapshot

RXRX : 3.38 (+1.50%)
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated targets...

RXRX : 3.38 (+1.50%)
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates highlighting...

RXRX : 3.38 (+1.50%)
Recursion's AI Drug Discovery Timeline Gets Its Quarterly Reality Check

Barchart Research What to Expect from RXRX Earnings RXRX Generated August 4, 2026 Current Price $3.31 EPS Estimate $$-0.23 Consensus Rating Moderate Buy Average Move 5.39% Recursion's AI Drug Discovery...

RXRX : 3.38 (+1.50%)
Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...

RXRX : 3.38 (+1.50%)
Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...

RXRX : 3.38 (+1.50%)
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically...

RXRX : 3.38 (+1.50%)
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on July 27, 2026,...

RXRX : 3.38 (+1.50%)
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th

Company to host public Earnings call on August 5th at 8:00 am ET / 6:00 am MT / 1:00 pm BST...

RXRX : 3.38 (+1.50%)
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th

Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) -- Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) – Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically...

RXRX : 3.38 (+1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 3.48
2nd Resistance Point 3.43
1st Resistance Point 3.38
Last Price 3.39
1st Support Level 3.28
2nd Support Level 3.23
3rd Support Level 3.18

See More

52-Week High 7.18
Fibonacci 61.8% 5.50
Fibonacci 50% 4.97
Fibonacci 38.2% 4.45
Last Price 3.39
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.